Trials / Completed
CompletedNCT05967806
A Study to Identify and Characterise Patients With Chronic Kidney Disease and Proteinuria
An International, Non-randomised, Non-interventional, Multicentre Study to Identify and Characterise Patients With CKD and High Proteinuria for Possible Participation in Future Renal Clinical Studies.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,575 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 130 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the D4325C00007 study is to identify and characterise patients with known or newly diagnosed CKD for possible participation in future renal clinical studies and to obtain an overview on current treatment choices for this patient group in different regions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | assessment | 2 ml volume of blood withdrawal |
Timeline
- Start date
- 2023-07-31
- Primary completion
- 2024-08-30
- Completion
- 2024-08-30
- First posted
- 2023-08-01
- Last updated
- 2025-04-06
Locations
80 sites across 14 countries: United States, Argentina, Brazil, Canada, China, India, Poland, Slovakia, South Africa, Sweden, Taiwan, Thailand, Turkey (Türkiye), Vietnam
Source: ClinicalTrials.gov record NCT05967806. Inclusion in this directory is not an endorsement.